🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide MASH Phase 2b — March 2026 Page 5

Survodutide MASH Phase 2b — March 2026

CanadaChris Fri, Aug 15, 2025 at 9:27 PM 31 replies 1,956 viewsPage 5 of 7
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Aug 20, 2025 at 12:04 PM#21
jason_paloalto said:
Practical: whatever you change, write down the date and the reason.

I read this differently from jason_paloalto, on substance rather than tone. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

6 4lucas_SP_BR, lisa_labSD, adam_van and 3 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Aug 21, 2025 at 9:03 PM#22
jason_paloalto said:
Practical: whatever you change, write down the date and the reason.

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

7 5pam_stl, wei_SG, cory_ATX and 4 others
Reply Quote Save Share Report
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Aug 23, 2025 at 6:01 AM#23
jason_paloalto said:
Practical: whatever you change, write down the date and the reason.

This answered a question I did not know how to ask. Adding it to my notes with a link back to this thread.

8 6Dr.Martinez, mike_mod, SarahChen_PharmD and 5 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Aug 24, 2025 at 2:59 PM#24

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

I would rather be corrected than agreed with, if it comes to it.

9 7Dr.Martinez, mike_mod, SarahChen_PharmD and 6 others
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
Aug 25, 2025 at 11:56 PM#25
VanRx_Mike said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

This matches mine closely enough to be worth saying so out loud. Nothing to add that would improve it.

Last edited: Aug 26, 2025 at 12:56 AM
10 8kevin_tulsa, Dr.PainCLE, mike_mealprep and 7 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register